Kinvent: Funding, Investors & Team (Sep 2026)
KINVENT is actively involved in the fields of physical rehabilitation and sports biomechanics producing innovative measuring and training devices for the facilitation of every day and athletic movements. Our strengths at KINVENT is that we can think and produce solutions to any challenge of sports biomechanics and physical rehabilitation. Triangular force plates for visual feedback balance training, sensors for continuous 3D kinematic analysis in the water, force sensors for kite surf, accelerometers for rowing and sailing, are some of our on demand products. If you are looking for excellence in hardware and software solutions for your work... work with us. Our KFORCE solution is a range of torque measuring instruments for human strength, balance and motion. This system consists of six instruments with high-precision measuring equipment, which concentrate all the know-how of K-INVENT. The display of the data recorded by the device sensors is transcribed by the KFORCE software, installed on any iOS or Android terminal. This accessory capable of reading and re-transcribing the information given by all dynamometers of the entire range is usable on smartphones or tablets with Android and IOS operating system
Kinvent has raised $17.4M across 1 funding round on record, the most recent a Series B of $17.4M announced in Jan 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Kinvent Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Kinvent Funding Rounds
Kinvent Founders and Leadership Team
Contact details for the Kinvent team: 1 of 1 has an email address on file.
Start 14-day free trial →Kinvent Funding Compared to Other Biotechnology Startups
Kinvent's latest round of $17.4M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Kinvent in Biotechnology and Montpellier
Companies Similar to Kinvent
Brenus Pharma is a platform that uses allogeneic techniques to create immune therapy with the goal of…
TISSIUM is a privately owned medical device company based in Paris, France that is dedicated to the rapid…
NicOx is a biopharmaceutical company that focuses on creating and selling nitric oxide-donating drugs for…
Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from…
One Biosciences was founded in Paris, Ile-de-France, France by Magali Richard, David Schilansky, and Céline…
Inventiva Pharma is a biopharmaceutical company in the clinical stage that focuses on creating oral small…
NETRIS Pharma develops therapeutic molecules for treating cancer by targeting dependence receptors for the…
AbIONYX Pharma is a biotechnology company that is focused on providing innovative therapies for indications…
Founded in 2003, Nanobiotix is at the forefront of nanomedicine and is committed to revolutionizing patient…
Theraclion specializes in high-tech medical equipment using high-intensity focused ultrasound (HIFU). They…
Abivax, a clinical stage biotechnology company, is mobilizing the body’s natural immune machinery to treat…
AB Science was established in 2001 by a group of individuals in the medical and business fields who are…
Kinvent Funding FAQs
What does Kinvent do?
KINVENT is actively involved in the fields of physical rehabilitation and sports biomechanics producing innovative measuring and training devices for the facilitation of every day and athletic movements. Our strengths at KINVENT is that we can think and produce solutions to any challenge of sports biomechanics and physical rehabilitation. Triangular force plates for visual feedback balance training, sensors for continuous 3D kinematic analysis in the water, force sensors for kite surf, accelerometers for rowing and sailing, are some of our on demand products. If you are looking for excellence in hardware and software solutions for your work... work with us. Our KFORCE solution is a range of torque measuring instruments for human strength, balance and motion. This system consists of six instruments with high-precision measuring equipment, which concentrate all the know-how of K-INVENT. The display of the data recorded by the device sensors is transcribed by the KFORCE software, installed on any iOS or Android terminal. This accessory capable of reading and re-transcribing the information given by all dynamometers of the entire range is usable on smartphones or tablets with Android and IOS operating system
How much funding has Kinvent raised?
Kinvent has raised $17.4M across 1 round on record. The most recent is a Series B of $17.4M announced in Jan 2024.
When did Kinvent last raise funding?
Kinvent's most recent funding round on record is a Series B of $17.4M, announced in Jan 2024.
Who founded Kinvent?
FundedIQ lists Athanase (athan) Kollias (Founder) at Kinvent.
Where is Kinvent headquartered?
Kinvent is based in Montpellier, Languedoc-Roussillon, France.
How many employees does Kinvent have?
Kinvent is in the 51-100 employee band.
How does Kinvent's funding compare to other Biotechnology startups?
Kinvent's latest round of $17.4M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Kinvent Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Kinvent is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.